241
Participants
Start Date
April 1, 2016
Primary Completion Date
July 2, 2019
Study Completion Date
October 30, 2020
Paclitaxel
Paclitaxel intravenous solution.
Sapanisertib
Sapanisertib capsules.
MLN1117
MLN1117 capsules.
Cliniques Universitaires Saint-Luc, Brussels
Westmead Hospital, Westmead
St George Hospital, Kogarah
GasthuisZusters Antwerpen Sint-Augustinus, Wilrijk
UZ Antwerpen, Edegem
Peter MacCallum Cancer Centre-East Melbourne, Melbourne
UZ Leuven, Leuven
Sunshine Hospital, Footscray
Cabrini Hospital Malvern, Malvern
Monash Medical Centre Clayton, Clayton
Centre Hospitalier Universitaire de Liege Site Sart Tilman, Liège
Stavanger University Hospital, Stavanger
Royal Brisbane and Women's Hospital, Herston
Haukeland universitetssykehus, Kvinneklinikken, Bergen
NYU Langone Medical Center Clinic, New York
Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum, Berlin
University of Pittsburgh Medical Center Cancer Center at Magee-Womens Hospital, Pittsburgh
Ente Ospedaliero Ospedali Galliera, Genova
Universitaetsmedizin Greifswald, Greifswald
Fox Chase Cancer Center, Philadelphia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
IEO Istituto Europeo di Oncologia, Milan
Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck
Spedali Civili di Brescia, Brescia
MD Anderson Cancer Centre, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Clinico San Carlos, Madrid
Hospital Universitario La Paz, Madrid
Centro Integral Oncologico Clara Campal, Madrid
Levine Cancer Institute, Charlotte
Medizinische Hochschule Hannover, Hanover
Augusta University, Augusta
Florida Cancer Specialists, West Palm Beach
Sarah Cannon Research Institute, Nashville
Instituto Valenciano de Oncologia IVO, Valencia
Franciscan St. Francis Health, Indianapolis
Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola
Azienda Unita Sanitaria Locale di Ravenna, Ravenna
Washington University, St Louis
University of Kansas Medical Center Research Institute, Inc., Westwood
Oklahoma University Health Sciences Center, Oklahoma City
University of Texas Southwestern Medical Center, Dallas
Istituto Tumori Napoli Fondazione G. Pascale, Napoli
University of Arizona Cancer Center, Phoenix
University of California at San Francisco (PARENT), San Francisco
Stanford School of Medicine, Stanford
Marin Cancer Care, Greenbrae
University of Alabama Comprehensive Cancer Center, Birmingham
University of California San Diego Medical Center, La Jolla
H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Massachusetts General Hospital Cancer Center, Boston
Memorial Sloan Kettering Cancer Center, New York
Tom Baker Cancer Centre, Calgary
Juravinski Cancer Clinic, Hamilton
LHSC - Victoria Hospital, London
Ottawa Hospital Cancer Centre, Ottawa
University Health Network - Princess Margaret Cancer Centre, Toronto
CHUM Hopital Notre-Dame, Montreal
Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden
Istituto Nationale Tumori Regina Elena, Roma
"Universita degli Studi di Roma La Sapienza - Umberto I Policlinico di Roma", Roma
Fondazione Policlinico Universitario Agostino Gemelli, Roma
Maastricht Universitair Medisch Centrum, Maastricht
Academisch Medisch Centrum, Amsterdam
Erasmus Medisch Centrum Daniel den Hoed, Rotterdam
Universitair Medisch Centrum Groningen, Groningen
Universitair Medisch Centrum Utrecht, Utrecht
Radiumhospitalet, Oslo
Hospital Universitari Vall d'Hebron, Barcelona
Bristol Haematology and Oncology Centre, Bristol
Royal Devon and Exeter Hospital (Wonford), Exeter
University College London Hospitals, London
Royal Marsden Hospital, London
Hammersmith Hospital, London
The Christie, Manchester
Royal Marsden Hospital, Sutton
University Hospital Coventry, Coventry
Beatson West of Scotland Cancer Centre, Glasgow
Lead Sponsor
European Network of Translational Research in Ovarian Cancer - EUTROC
UNKNOWN
European Network of Individualized Treatment in Endometrial Cancer - ENITEC
OTHER_GOV
Millennium Pharmaceuticals, Inc.
INDUSTRY